Abstract:

Objective： To analyze the effect of thoracoscopic small-incision surgery for the treatment of lung cancer. Methods： A total of 76 patients with lung cancer admitted to the First Affiliated Hospital of Dali University from March 2020 to March 2022 were studied. The patients were randomly divided into two groups by the principle of double-blind grouping. The control group was treated with traditional thoracotomy， while the observation group was treated with thoracoscopic small-incision surgery. The surgical indicators， coagulation function indicators， complication rate， recurrence rate and quality of life were compared between two groups. Results： The surgical time of the observation group was similar to that of the control group， with no statistical significance （P>0.05）. Compared with the control group， the observation group had less intraoperative blood loss， shorter postoperative catheterization time and hospital stay， more lymph node dissection， and longer postoperative analgesia time， with statistical significance（P<0.05）. There was no significant difference in the coagulation function indicators 24 hours after surgery between two groups（P>0.05）. The score of postoperative quality of life in observation group was significantly higher than that of the control group， while the incidence of complications and recurrence rate in the control group were significantly higher than those in the observation group（P<0.05）. Conclusion： Thoracoscopic small-incision surgery is effective in the treatment of lung cancer. Compared with traditional thoracotomy， it has similar surgical difficulty and duration， but causes less damage to patients， promotes faster recovery， and has a lower recurrence rate， which is beneficial for improving the quality of life of patients and deserves promotion.

Key words:

thoracoscope, small-incision surgery, lung cancer, coagulation function